Table 4A: Cox-regression. Prognostic factors for disease-free survival for the
whole series of patients (n=253).
|
Adjusted results |
||||||||
|
Variable |
HR |
-95% C.I. |
+95% C.I. |
HR |
-95% C.I. |
+95% C.I. |
p-value |
|
|
Age |
1,022 |
1,002 |
1,042 |
1,008 |
0,985 |
1,032 |
0,488 |
|
|
FIGO-stage |
|
|
|
|
|
|
0,000 |
|
|
IA |
0,104 |
0,031 |
0,352 |
0,186 |
0,043 |
0,809 |
0,025 |
|
|
IB |
0,193 |
0,101 |
0,367 |
0,181 |
0,086 |
0,383 |
0,000 |
|
|
IIA |
0,230 |
0,068 |
0,780 |
0,235 |
0,066 |
0,837 |
0,025 |
|
|
IIB |
Reference |
Reference |
||||||
|
Histopathology |
|
|
|
|
|
|
0,009 |
|
|
Adeno-carcinom |
0,307 |
0,114 |
0,826 |
0,190 |
0,060 |
0,601 |
0,005 |
|
|
Squamous cell |
0,422 |
0,188 |
0,950 |
0,310 |
0,130 |
0,739 |
0,008 |
|
|
Adeno-squam. |
Reference |
Reference |
||||||
|
Tumor grade |
|
|
|
|
|
|
0,305 |
|
|
G1 |
6,072 |
0,757 |
48,682 |
6,471 |
0,642 |
65,235 |
0,113 |
|
|
G2 |
8,366 |
1,103 |
63,455 |
5,156 |
0,540 |
49,233 |
0,154 |
|
|
G3 |
8,553 |
1,147 |
63,808 |
3,618 |
0,365 |
35,893 |
0,272 |
|
|
Ungraded |
Reference |
Reference |
||||||